SCHEMBL8868071

SCHEMBL8868071

O=C(NC1CCCCC1)c1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCCO)nc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.55
TSHR P16473 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
BLM P54132 2/20 0.55
CYP3A4 P08684 1/20 0.55
HTR1A P08908 1/20 0.55
MAPT P10636 1/20 0.55
CYP2C9 P11712 1/20 0.55
NFKB1 P19838 1/20 0.55
CNR1 P21554 1/20 0.55
CYP2C19 P33261 1/20 0.55
ADRA1A P35348 1/20 0.55
HTT P42858 1/20 0.50
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 4/20 0.48
GAA P10253 1/20 0.48
GFER P55789 1/20 0.48
P4HTM Q9NXG6 2/20 0.48
THRB P10828 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869950 0.90 LMNA (0.54) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8870465 0.90 LMNA (0.52) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8869693 0.89 HSD17B10 (0.50) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8867992 0.88 LMNA (0.51) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8868631 0.88 LMNA (0.51) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL9140492 0.87 P4HTM (0.65) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL7867896 0.85 LMNA (0.49) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8869818 0.85 LMNA (0.51) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8868039 0.84 LMNA (0.48) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8869050 0.84 SMN1; SMN2 (0.49) LMNATSHRSMN1; SMN2BLMCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed